Connection
Megan Kelsey to alpha-MSH
This is a "connection" page, showing publications Megan Kelsey has written about alpha-MSH.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.237 |
|
|
|
-
Argente J, Verge CF, Okorie U, Fennoy I, Kelsey MM, Cokkinias C, Scimia C, Lee HM, Farooqi IS. Setmelanotide in patients aged 2-5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial. Lancet Diabetes Endocrinol. 2025 01; 13(1):29-37.
Score: 0.237